Trials / Unknown
UnknownNCT01226615
Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)
Randomized, Double-blind, Placebo-controlled Study to Asses the Effect of Chondroitin Sulphate in Patients With Knee Osteoarthritis by Functional Magnetic Resonance Imaging
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Bioiberica · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main purposes of this study are: * to determine the effects of chondroitin sulphate on brain response to pain assessed through fMRI in patients with knee osteoarthritis. * to investigate the relationship between treatment response detected by fMRI and the results of the different parameters of clinical assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chondroitin sulphate (Condrosan®) | 800mg (two capsules of 400mg each) taken once a day for four months |
| DRUG | Placebo | Two placebo capsules taken once a day for four months. |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Completion
- 2012-12-01
- First posted
- 2010-10-22
- Last updated
- 2012-10-02
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01226615. Inclusion in this directory is not an endorsement.